Dicot Pharma ABOMXSTO: DICOT

Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.

· Issued by Dicot Pharma AB

On 6ix: 6ix.com/news/dicot-pharma-gets-fda-clearance-to-start-first-part-of-phase-2b-study-with-lib-01-in-us

Dicot Pharma AB OMXSTO:DICOT:

  • RECEIVES FDA CLEARANCE TO INITIATE THE FIRST PART OF THE PHASE 2B STUDY WITH LIB-01 IN THE U.S.

  • APPLICATION TO COMMENCE STUDY IN EUROPE WILL BE SUBMITTED TO RELEVANT REGULATORY AUTHORITIES IN Q3

  • STUDY IS EXPECTED TO START IN SECOND HALF OF 2026, IN LINE WITH PREVIOUSLY COMMUNICATED TIMELINE

Dicot Pharma AB on 6ix

Earlier from Dicot Pharma

Later from Dicot Pharma

All Dicot Pharma news releases